Immunosuppression and Rejection Management

fective immunosuppression is essential to prevent organ rejection after transplantation. Advances in targeted therapies and personalized medicine are improving patient outcomes. Modern immunosuppressive drugs minimize side effects while maintaining graft acceptance. Monitoring biomarkers and immune responses allows clinicians to tailor treatments for individual patients.

    Related Conference of Immunosuppression and Rejection Management

    May 14-15, 2026

    6th World Congress on Surgery

    London, UK
    September 14-15, 2026

    12th European Otolaryngology-ENT Surgery Conference

    Rome, Italy
    October 27-28, 2026

    3rd Global Summit on Geriatrics & Aging

    Rome, Italy
    December 03-04, 2026

    9th Annual Summit on Surgery and Transplantation

    Madrid, Spain

    Immunosuppression and Rejection Management Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in